1.
Eandi M. Pharmacoeconomic aspects of poor adherence to treatment in multiple sclerosis management. Farmeconomia. Health Economics and Therapeutic Pathways. 2011;12(3):107-117. https://doi.org/10.7175/fe.v12i3.127